134 related articles for article (PubMed ID: 7526760)
21. [Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinase by myofibroblasts--morphological study on corneal wound healing].
Shimoda M; Ishizaki M; Saiga T; Yamanaka N
Nippon Ganka Gakkai Zasshi; 1997 May; 101(5):371-9. PubMed ID: 9170840
[TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinase-9 in tumor cell invasion.
French DL; Ramos-DeSimone N; Rozinski K; Nuovo GJ
Ann N Y Acad Sci; 1994 Sep; 732():324-34. PubMed ID: 7978802
[No Abstract] [Full Text] [Related]
23. Correspondence re: N-B. Liabakk et al., matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res., 56: 190-196, 1966.
Zucker S
Cancer Res; 1996 Aug; 56(15):3610. PubMed ID: 8758934
[No Abstract] [Full Text] [Related]
24. Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.
Chapman KT; Kopka IE; Durette PL; Esser CK; Lanza TJ; Izquierdo-Martin M; Niedzwiecki L; Chang B; Harrison RK; Kuo DW
J Med Chem; 1993 Dec; 36(26):4293-301. PubMed ID: 8277511
[TBL] [Abstract][Full Text] [Related]
25. Defects in matrix metalloproteinase inhibitory stoichiometry and selective MMP induction in patients with nonischemic or ischemic dilated cardiomyopathy.
Coker ML; Zellner JL; Crumbley AJ; Spinale FG
Ann N Y Acad Sci; 1999 Jun; 878():559-62. PubMed ID: 10415772
[No Abstract] [Full Text] [Related]
26. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
[TBL] [Abstract][Full Text] [Related]
27. Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells.
Duivenvoorden WC; Hirte HW; Singh G
Invasion Metastasis; 1997; 17(6):312-22. PubMed ID: 9949290
[TBL] [Abstract][Full Text] [Related]
28. 92K-GL (MMP-9) and 72K-GL (MMP-2) are produced in vivo by human oral squamous cell carcinomas and can enhance FIB-CL (MMP-1) activity in vitro.
Pickett KL; Harber GJ; DeCarlo AA; Louis P; Shaneyfelt S; Windsor LJ; Bodden MK
J Dent Res; 1999 Jul; 78(7):1354-61. PubMed ID: 10403463
[TBL] [Abstract][Full Text] [Related]
29. Gelatinolytic and type IV collagenolytic activity in bronchiectasis.
Sepper R; Konttinen YT; Sorsa T; Koski H
Chest; 1994 Oct; 106(4):1129-33. PubMed ID: 7924484
[TBL] [Abstract][Full Text] [Related]
30. Regulation of matrix metalloproteinase activity.
Murphy G; Willenbrock F; Crabbe T; O'Shea M; Ward R; Atkinson S; O'Connell J; Docherty A
Ann N Y Acad Sci; 1994 Sep; 732():31-41. PubMed ID: 7978800
[No Abstract] [Full Text] [Related]
31. The interactions of alpha 2HS glycoprotein with metalloproteinases.
Ochieng J; Green B
Biochem Mol Biol Int; 1996 Sep; 40(1):13-20. PubMed ID: 8886265
[TBL] [Abstract][Full Text] [Related]
32. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.
Imai K; Ohuchi E; Aoki T; Nomura H; Fujii Y; Sato H; Seiki M; Okada Y
Cancer Res; 1996 Jun; 56(12):2707-10. PubMed ID: 8665498
[TBL] [Abstract][Full Text] [Related]
33. MMPs are IGFBP-degrading proteinases: implications for cell proliferation and tissue growth.
Fowlkes JL; Serra DM; Nagase H; Thrailkill KM
Ann N Y Acad Sci; 1999 Jun; 878():696-9. PubMed ID: 10415811
[No Abstract] [Full Text] [Related]
34. ADAMTS-1 is an active metalloproteinase associated with the extracellular matrix.
Kuno K; Terashima Y; Matsushima K
J Biol Chem; 1999 Jun; 274(26):18821-6. PubMed ID: 10373500
[TBL] [Abstract][Full Text] [Related]
35. [Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC), analyzed by immunohistochemical study].
Matsumoto F; Uzuki M; Kaneko C; Rikimaru A; Kokubun S; Sawai T
Ryumachi; 1997 Oct; 37(5):688-95. PubMed ID: 9396371
[TBL] [Abstract][Full Text] [Related]
36. [Molecular mechanism of invadopodia formation].
Nakahara H
Tanpakushitsu Kakusan Koso; 1998 Apr; 43(5):669-75. PubMed ID: 9564784
[No Abstract] [Full Text] [Related]
37. Clinical importance of metalloproteinases and their inhibitors.
Krane SM
Ann N Y Acad Sci; 1994 Sep; 732():1-10. PubMed ID: 7978783
[No Abstract] [Full Text] [Related]
38. Collagenolytic activities with differentiation of the cultured cells from the murine hair apparatus.
Obana N; Ito M; Kobayashi T; Nagai Y
J Dermatol Sci; 1996 Oct; 13(1):83-6. PubMed ID: 8902658
[TBL] [Abstract][Full Text] [Related]
39. [Membrane-type matrix metalloproteinases--unique structure and functions].
Sato H
Seikagaku; 1997 Nov; 69(11):1277-81. PubMed ID: 9431018
[No Abstract] [Full Text] [Related]
40. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3.
Cowell S; Knäuper V; Stewart ML; D'Ortho MP; Stanton H; Hembry RM; López-Otín C; Reynolds JJ; Murphy G
Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):453-8. PubMed ID: 9531484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
